Figures of the Article
-
IDH1-AS1 was downregulated in EOC cells and was associated with the prognosis of EOC.
-
IDH1-AS1 inhibited the proliferation of EOC cells in vitro.
-
IDH1-AS1 acted by sponging miR-518c-5p in EOC cells.
-
IDH1-AS1 affected EOC cells by targeting the miR-518c-5p/RBM47 axis.
-
IDH1-AS1 suppressed tumor growth of EOC in vivo.
-
A mechanism schematic of the role of IDH1-AS1 in EOC.
Related articles
-
2025, 39(3): 286-304. DOI: 10.7555/JBR.38.20240190
-
2025, 39(2): 214-214. DOI: 10.7555/JBR.39.20250900
-
2024, 38(2): 163-174. DOI: 10.7555/JBR.37.20220249
-
2022, 36(4): 231-241. DOI: 10.7555/JBR.36.20220049
-
2019, 33(6): 382-390. DOI: 10.7555/JBR.33.20180078
-
2019, 33(6): 371-381. DOI: 10.7555/JBR.33.20190015
-
Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer2018, 32(6): 424-433. DOI: 10.7555/JBR.32.20170065
-
2018, 32(5): 336-342. DOI: 10.7555/JBR.32.20170096
-
2012, 26(4): 274-277. DOI: 10.7555/JBR.26.20110103
-
2010, 24(3): 187-197.